Comprehensive management of cholangiocarcinoma: Part II. Treatment

키워드

참고문헌 (168)

1. Lee SY, "Operative management of cholangiocarcinoma", Semin Liver Dis, 33, pp.248~261 (2013)
2. Sewnath ME, "A metaanalysis on the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice", Ann Surg, 236, pp.17~27 (2002)
3. Garcea G, "Preoperative biliary drainage for distal obstruction : the case against revisited", Pancreas, 39, pp.119~126 (2010)
4. Smith RA, "Preoperative resolution of jaundice following biliary stenting predicts more favourable early survival in resected pancreatic ductal adenocarcinoma", Ann Surg Oncol, 15, pp.3138~3146 (2008)
5. Coates JM, "Negligible effect of selective preoperative biliary drainage on perioperative resuscitation, morbidity, and mortality in patients undergoing pancreaticoduodenectomy", Arch Surg, 144, pp.841~847 (2009)
6. van der Gaag NA, "Preoperative biliary drainage for cancer of the head of the pancreas", N Engl J Med, 362, pp.129~137 (2010)
7. Baron TH, "Preoperative biliary stents in pancreatic cancer--proceed with caution", N Engl J Med, 362, pp.170~172 (2010)
8. Liu F, "Preoperative biliary drainage before resection for hilar cholangiocarcinoma : whether or not? A systematic review", Dig Dis Sci, 56, pp.663~672 (2011)
9. Lee SG, "Surgical treatment of hilar cholangiocarcinoma in the new era : the Asan experience", J Hepatobiliary Pancreat Sci, 17, pp.476~489 (2010)
10. Farges O, "Multicentre European study of preoperative biliary drainage for hilar cholangiocarcinoma", Br J Surg, 100, pp.274~283 (2013)
11. Arakura N, "Efficacy of preoperative endoscopic nasobiliary drainage for hilar cholangiocarcinoma", J Hepatobiliary Pancreat Surg, 16, pp.473~477 (2009)
12. Kawakami H, "Endoscopic nasobiliary drainage is the most suitable preoperative biliary drainage method in the management of patients with hilar cholangiocarcinoma", J Gastroenterol, 46, pp.242~248 (2011)
13. Rocha FG, "Hilar cholangiocarcinoma : the Memorial Sloan-Kettering Cancer Center experience", J Hepatobiliary Pancreat Sci, 17, pp.490~496 (2010)
14. Lee JH, "Self-expandable metal stents for malignant distal biliary strictures", Gastrointest Endosc Clin N Am, 21, pp.463~480 (2011)
15. Iacono C, "Role of preoperative biliary drainage in jaundiced patients who are candidates for pancreatoduodenectomy or hepatic resection : highlights and drawbacks", Ann Surg, 257, pp.191~204 (2013)
16. Larghi A, "Management of hilar biliary strictures", Am J Gastroenterol, 103, pp.458~473 (2008)
17. Shah KN, "Endoscopic and percutaneous approaches to the treatment of biliary tract and primary liver tumors : controversies and advances", Surg Oncol Clin N Am, 23, pp.207~230 (2014)
18. Iwashita T, "Endoscopic ultrasound-guided biliary drainage : a review", Clin J Gastroenterol, 7, pp.94~102 (2014)
19. Poincloux L, "Endoscopic ultrasound-guided biliary drainage after failed ERCP : cumulative experience of 101 procedures at a single center", Endoscopy, 47, pp.794~801 (2015)
20. Khashab MA, "A comparative evaluation of EUS-guided biliary drainage and percutaneous drainage in patients with distal malignant biliary obstruction and failed ERCP", Dig Dis Sci, 60, pp.557~565 (2015)
21. Gupta K, "Endoscopic ultrasound-assisted bile duct access and drainage : multicenter, long-term analysis of approach, outcomes, and complications of a technique in evolution", J Clin Gastroenterol, 48, pp.80~87 (2014)
22. Banerjee N, "Endoscopic biliary sphincterotomy is not required for transpapillary SEMS placement for biliary obstruction", Dig Dis Sci, 56, pp.591~595 (2011)
23. Dumonceau JM, "Biliary stenting : indications, choice of stents and results : European Society of Gastrointestinal Endoscopy(ESGE)clinical guideline", Endoscopy, 44, pp.277~298 (2012)
24. Khashab MA, "Antibiotic prophylaxis for GI endoscopy", Gastrointest Endosc, 81, pp.81~89 (2015)
25. Saxena P, "Endoscopic management of acute cholecystitis after metal stent placement in patients with malignant biliary obstruction : a case series", Gastrointest Endosc, 78, pp.175~178 (2013)
26. Bragazzi MC, "Cholangiocarcinoma : epidemiology and risk factors", Translational Gastrointestinal Cancer, 1, pp.21~32 (2012)
27. Deviere J, "Long-term follow-up of patients with hilar malignant stricture treated by endoscopic internal biliary drainage", Gastrointest Endosc, 34, pp.95~101 (1988)
28. Rerknimitr R, "Asia-Pacific consensus recommendations for endoscopic and interventional management of hilar cholangiocarcinoma", J Gastroenterol Hepatol, 28, pp.593~607 (2013)
29. Paik WH, "Palliative treatment with self-expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma : a percutaneous versus endoscopicapproach", Gastrointest Endosc, 69, pp.55~62 (2009)
30. Mukai T, "Metallic stents are more efficacious than plastic stents in unresectable malignant hilar biliary strictures : a randomized controlled trial", J Hepatobiliary Pancreat Sci, 20, pp.214~222 (2013)
31. Naitoh I, "Unilateral versus bilateral endoscopic metal stenting for malignant hilar biliary obstruction", J Gastroenterol Hepatol, 24, pp.552~557 (2009)
32. Liberato MJ, "Endoscopic stenting for hilar cholangiocarcinoma : efficacy of unilateral and bilateral placement of plastic and metal stents in a retrospective review of 480 patients", BMC Gastroenterol, 12, pp.103~ (2012)
33. 이태훈, "Bilateral Metallic Stenting in Malignant Hilar Obstruction", Clinical Endoscopy, 47(5), pp.440~446 (2014), 대한소화기내시경학회
34. Kogure H, "High single-session success rate of endoscopic bilateral stent-in-stent placement with modified large cell Niti-S stents for malignant hilar biliary obstruction", Dig Endosc, 26, pp.93~99 (2014)
35. Law R, "Bilateral metal stents for hilar biliary obstruction using a 6Fr delivery system : outcomes following bilateral and side-by-side stent deployment", Dig Dis Sci, 58, pp.2667~2672 (2013)
36. De Palma GD, "Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction : results of a prospective, randomized, and controlled study", Gastrointest Endosc, 53, pp.547~553 (2001)
37. Iwano H, "Unilateral versus bilateral drainage using self-expandable metallic stent for unresectable hilar biliary obstruction", Dig Endosc, 23, pp.43~48 (2011)
38. Sawas T, "Self-expandable metal stents versus plastic stents for malignant biliary obstruction: a meta-analysis", Gastrointest Endosc, 82, pp.256~267 (2015)
39. Srinivasan I, "Metal stents for hilar lesions", Gastrointest Endosc Clin N Am, 22, pp.555~565 (2012)
40. De Palma GD, "Unilateral placement of metallic stents for malignant hilar obstruction : a prospective study", Gastrointest Endosc, 58, pp.50~53 (2003)
41. Cheng JL, "Endoscopic palliation of patients with biliary obstruction caused by nonresectable hilar cholangiocarcinoma : efficacy of self-expandable metallic Wallstents", Gastrointest Endosc, 56, pp.33~39 (2002)
42. Lee JH, "Endoscopic bilateral metal stent placement for advanced hilar cholangiocarcinoma : a pilot study of a newly designed Y stent", Gastrointest Endosc, 66, pp.364~369 (2007)
43. Kanno Y, "Single-session endoscopic bilateral y-configured placement of metal stents for hilar malignant biliary obstruction", Dig Endosc, 23, pp.91~96 (2011)
44. Hwang JC, "Y-shaped endoscopic bilateral metal stent placement for malignant hilar biliary obstruction : prospective long-term study", Scand J Gastroenterol, 46, pp.326~332 (2011)
45. Kim DU, "Bilateral biliary drainage for malignant hilar obstruction using the ‘stent-in-stent’ method with a Y-stent : efficacy and complications", Eur J Gastroenterol Hepatol, 25, pp.99~106 (2013)
46. Di Mitri R, "Y-shaped bilateral self-expandable metallic stent placement for malignant hilar biliary obstruction : data from a referral center for palliative care", ScientificWorldJournal, 2014, pp.151502~ (2014)
47. Park do H, "Newly designed stent for endoscopic bilateral stent-in-stent placement of metallic stents in patients with malignant hilar biliary strictures : multicenter prospective feasibility study(with videos)", Gastrointest Endosc, 69, pp.1357~1360 (2009)
48. Lee JM, "Small cell-versus large cell-sized metal stent in endoscopic bilateral stent-in-stent placement for malignant hilar biliary obstruction", Dig Endosc, 27, pp.692~699 (2015)
49. Uchida D, "Efficacy of endoscopic over 3-branched partial stent-in-stent drainage using self-expandable metallic stents in patients with unresectable hilar biliary carcinoma", J Clin Gastroenterol, 49, pp.529~536 (2015)
50. Kawamoto H, "Endoscopic 3-branched partial stent-in-stent deployment of metallic stents in high-grade malignant hilar biliary stricture(with videos)", Gastrointest Endosc, 66, pp.1030~1037 (2007)
51. Kawamoto H, "Endoscopic deployment of multiple JOSTENT SelfX is effective and safe in treatment of malignant hilar biliary strictures", Clin Gastroenterol Hepatol, 6, pp.401~408 (2008)
52. Soderlund C, "Covered metal versus plastic stents for malignant common bile duct stenosis : a prospective, randomized, controlled trial", Gastrointest Endosc, 63, pp.986~995 (2006)
53. Isayama H, "A prospective randomised study of"covered"versus"uncovered"diamond stents for the management of distal malignant biliary obstruction", Gut, 53, pp.729~734 (2004)
54. Yoon WJ, "A comparison of covered and uncovered Wallstents for the management of distal malignant biliary obstruction", Gastrointest Endosc, 63, pp.996~1000 (2006)
55. Kullman E, "Covered versus uncovered self-expandable nitinol stents in the palliative treatment of malignant distal biliary obstruction : results from a randomized, multicenter study", Gastrointest Endosc, 72, pp.915~923 (2010)
56. Telford JJ, "A randomized trial comparing uncovered and partially covered self-expandable metal stents in the palliation of distal malignant biliary obstruction", Gastrointest Endosc, 72, pp.907~914 (2010)
57. Lee JH, "Comparison of the utility of covered metal stents versus uncovered metal stents in the management of malignant biliary strictures in 749 patients", Gastrointest Endosc, 78, pp.312~324 (2013)
58. Kahaleh M, "Evaluation of a fully covered self-expanding metal stent with flared ends in malignant biliary obstruction: a multicenter study", J Clin Gastroenterol, 47, pp.e96~e100 (2013)
59. Cavell LK, "Biliary selfexpandable metal stents do not adversely affect pancreaticoduodenectomy", Am J Gastroenterol, 108, pp.1168~1173 (2013)
60. Pop GH, "Bridge to surgery using partially covered self-expandable metal stents (PCMS) in malignant biliary stricture: an acceptable paradigm?", Surg Endosc, 25, pp.613~618 (2011)
61. Kim YS, "Endoscopic ultrasound rendezvous for bile duct access using a transduodenal approach: cumulative experience at a single center. A case series", Endoscopy, 42, pp.496~502 (2010)
62. Khashab MA, "EUS-guided biliary drainage by using a standardized approach for malignant biliary obstruction : rendezvous versus direct transluminal techniques(with videos)", Gastrointest Endosc, 78, pp.734~741 (2013)
63. Dhir V, "Multicenter comparative evaluation of endoscopic placement of expandable metal stents for malignant distal common bile duct obstruction by ERCP or EUS-guided approach", Gastrointest Endosc, 81, pp.913~923 (2015)
64. Razumilava N, "Classification, diagnosis, and management of cholangiocarcinoma", Clin Gastroenterol Hepatol, 11, pp.13~21 (2013)
65. Bridgewater J, "Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma", J Hepatol, 60, pp.1268~1289 (2014)
66. Agrawal S, "Oncologic resection for malignant tumors of the liver", Ann Surg, 253, pp.656~665 (2011)
67. Spolverato G, "Conditional probability of long-term survival after liver resection for intrahepatic cholangiocarcinoma : a multi-institutional analysis of 535 patients", JAMA Surg, 150, pp.538~545 (2015)
68. Bergeat D, "Extended liver resections for intrahepatic cholangiocarcinoma: friend or foe?", Surgery, 157, pp.656~665 (2015)
69. Zimmitti G, "Greater complexity of liver surgery is not associated with an increased incidence of liverrelated complications except for bile leak : an experience with 2, 628 consecutive resections", J Gastrointest Surg, 17, pp.57~64 (2013)
70. Spolverato G, "Readmission after liver resection for intrahepatic cholangiocarcinoma : a multiinstitutional analysis", J Gastrointest Surg, 19, pp.1334~1341 (2015)
71. Hyder O, "Recurrence after operative management of intrahepatic cholangiocarcinoma", Surgery, 153, pp.811~818 (2013)
72. Weber SM, "Intrahepatic cholangiocarcinoma : resectability, recurrence pattern, and outcomes", J Am Coll Surg, 193, pp.384~391 (2001)
73. Shimada K, "Therapeutic value of lymph node dissection during hepatectomy in patients with intrahepatic cholangiocellular carcinoma with negative lymph node involvement", Surgery, 145, pp.411~416 (2009)
74. Shimada M, "Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma", Br J Surg, 88, pp.1463~1466 (2001)
75. Uchiyama K, "Impact of nodal involvement on surgical outcomes of intrahepatic cholangiocarcinoma : a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery", J Hepatobiliary Pancreat Sci, 18, pp.443~452 (2011)
76. Marubashi S, "Prediction of the postoperative prognosis of intrahepatic cholangiocarcinoma(ICC) : importance of preoperatively-determined anatomic invasion level and number of tumors", Dig Dis Sci, 59, pp.201~213 (2014)
77. Zaydfudim VM, "Hilar cholangiocarcinoma", Surg Oncol Clin N Am, 23, pp.247~263 (2014)
78. Nimura Y, "Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus", World J Surg, 14, pp.535~543 (1990)
79. Higuchi R, "Improved surgical outcomes for hilar cholangiocarcinoma : changes in surgical procedures and related outcomes based on 40 years of experience at a single institution", Surg Today, 46, pp.74~83 (2016)
80. Ebata T, "Hepatopancreatoduodenectomy for cholangiocarcinoma : a single-center review of 85 consecutive patients", Ann Surg, 256, pp.297~305 (2012)
81. Xiang S, "Hilar cholangiocarcinoma : controversies on the extent of surgical resection aiming at cure", Int J Colorectal Dis, 30, pp.159~171 (2015)
82. Higuchi R, "Indications for portal vein embolization in perihilar cholangiocarcinoma", J Hepatobiliary Pancreat Sci, 21, pp.542~549 (2014)
83. Lee JH, "The proximal margin of resected hilar cholangiocarcinoma : the effect of microscopic positive margin on long-term survival", Am Surg, 78, pp.471~477 (2012)
84. Seyama Y, "Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate", Ann Surg, 238, pp.73~83 (2003)
85. Schiffman SC, "Overall survival peri-hilar cholangiocarcinoma : R1 resection with curative intent compared to primary endoscopic therapy", J Surg Oncol, 105, pp.91~96 (2012)
86. Igami T, "Surgical treatment of hilar cholangiocarcinoma in the"new era" : the Nagoya University experience", J Hepatobiliary Pancreat Sci, 17, pp.449~454 (2010)
87. Cannon RM, "Surgical resection for hilar cholangiocarcinoma : experience improves resectability", HPB(Oxford), 14, pp.142~149 (2012)
88. Saxena A, "Improved outcomes after aggressive surgical resection of hilar cholangiocarcinoma : a critical analysis of recurrence and survival", Am J Surg, 202, pp.310~320 (2011)
89. Ebata T, "Hepatectomy with portal vein resection for hilar cholangiocarcinoma : audit of 52 consecutive cases", Ann Surg, 238, pp.720~727 (2003)
90. de Jong MC, "The impact of portal vein resection on outcomes for hilar cholangiocarcinoma : a multiinstitutional analysis of 305 cases", Cancer, 118, pp.4737~4747 (2012)
91. Abbas S, "Systematic review and meta-analysis of the role of vascular resection in the treatment of hilar cholangiocarcinoma", HPB(Oxford), 15, pp.492~503 (2013)
92. Lee SG, "One hundred and eleven liver resections for hilar bile duct cancer", J Hepatobiliary Pancreat Surg, 7, pp.135~141 (2000)
93. Neuhaus P, "Oncological superiority of hilar en bloc resection for the treatment of hilar cholangiocarcinoma", Ann Surg Oncol, 19, pp.1602~1608 (2012)
94. Kambakamba P, "Perihilar cholangiocarcinoma : paradigms of surgical management", Am J Surg, 208, pp.563~570 (2014)
95. Aoba T, "Assessment of nodal status for perihilar cholangiocarcinoma : location, number, or ratio of involved nodes", Ann Surg, 257, pp.718~725 (2013)
96. Guglielmi A, "Prognostic significance of lymph node ratio after resection of peri-hilar cholangiocarcinoma", HPB(Oxford), 13, pp.240~245 (2011)
97. Chen W, "Combined portal vein resection in the treatment of hilar cholangiocarcinoma : a systematic review and meta-analysis", Eur J Surg Oncol, 40, pp.489~495 (2014)
98. Dickson PV, "Distal cholangiocarcinoma", Surg Clin North Am, 94, pp.325~342 (2014)
99. Lad N, "Distal cholangiocarcinoma", Surg Oncol Clin N Am, 23, pp.265~287 (2014)
100. Schulick RD, "Criteria of unresectability and the decision-making process", HPB(Oxford), 10, pp.122~125 (2008)
101. Murakami Y, "Prognostic factors after surgical resection for intrahepatic, hilar, and distal cholangiocarcinoma", Ann Surg Oncol, 18, pp.651~658 (2011)
102. DeOliveira ML, "Cholangiocarcinoma : thirty-one-year experience with 564 patients at a single institution", Ann Surg, 245, pp.755~762 (2007)
103. Loehrer AP, "Cholangiocarcinoma: are North American surgical outcomes optimal?", J Am Coll Surg, 216, pp.192~200 (2013)
104. Khan SA, "Guidelines for the diagnosis and treatment of cholangiocarcinoma : an update", Gut, 61, pp.1657~1669 (2012)
105. Kiriyama M, "Prognostic impact of lymph node metastasis in distal cholangiocarcinoma", Br J Surg, 102, pp.399~406 (2015)
106. Razumilava N, "Liver transplantation for intrahepatic cholangiocarcinoma : authors’ reply", Lancet, 384, pp.1182~1183 (2014)
107. Hong JC, "Predictive index for tumor recurrence after liver transplantation for locally advanced intrahepatic and hilarcholangiocarcinoma", J Am Coll Surg, 212, pp.514~520 (2011)
108. Sapisochin G, "Intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma in patients undergoing liver transplantation : a Spanish matched cohort multicenter study", Ann Surg, 259, pp.944~952 (2014)
109. Sapisochin G, "“Very early” intrahepatic cholangiocarcinoma in cirrhotic patients: should liver transplantation be reconsidered in these patients?", Am J Transplant, 14, pp.660~667 (2014)
110. Darwish Murad S, "Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers", Gastroenterology, 143, pp.88~98 (2012)
111. Poruk KE, "Perioperative management of hilar cholangiocarcinoma", J Gastrointest Surg, 19, pp.1889~1899 (2015)
112. Rosen CB, "Liver transplantation for cholangiocarcinoma", Transpl Int, 23, pp.692~697 (2010)
113. Heimbach JK, "Transplantation for hilar cholangiocarcinoma", Liver Transpl, 10(10 Suppl 2), pp.S65~S68 (2004)
114. Heimbach JK, "Trans-peritoneal fine needle aspiration biopsy of hilar cholangiocarcinoma is associated with disease dissemination", HPB (Oxford), 13, pp.356~360 (2011)
115. Croome KP, "Is liver transplantation appropriate for patients with potentially resectable de novo hilar cholangiocarcinoma?", J Am Coll Surg, 221, pp.130~139 (2015)
116. DeOliveira ML, "Liver transplantation for cholangiocarcinoma : current best practice", Curr Opin Organ Transplant, 19, pp.245~252 (2014)
117. Kato A, "Surgical resection after downsizing chemotherapy for initially unresectable locally advanced biliary tract cancer : a retrospective single-center study", Ann Surg Oncol, 20, pp.318~324 (2013)
118. Tran TB, "Locally advanced intrahepatic cholangiocarcinoma : complete pathologic response to neoadjuvant chemotherapy followed by left hepatic trisectionectomy and caudate lobectomy", Dig Dis Sci, 60, pp.3226~3229 (2015)
119. Slupski MW, "Unexpected response to systemic chemotherapy in case of primarily nonresectable advanced disseminated intrahepatic cholangiocarcinoma", World J Surg Oncol, 5, pp.36~ (2007)
120. Walker EJ, "A patient with cholangiocarcinoma demonstrating pathologic complete response to chemotherapy: exploring the role of neoadjuvant therapy in biliary tract cancer", J Gastrointest Oncol, 5, pp.E88~E95 (2014)
121. Nelson JW, "Concurrent chemoradiotherapy in resected extrahepatic cholangiocarcinoma", Int J Radiat Oncol Biol Phys, 73, pp.148~153 (2009)
122. "National Comprehensive Cancer Network® (NCCN®). NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®): Hepatobiliary Cancers version 2" (2016)[URL]
123. Sur MD, "Defining the benefit of adjuvant therapy following resection for intrahepatic cholangiocarcinoma", Ann Surg Oncol, 22, pp.2209~2217 (2015)
124. Mavros MN, "Treatment and prognosis for patients with intrahepatic cholangiocarcinoma : systematic review and meta-analysis", JAMA Surg, 149, pp.565~574 (2014)
125. Horgan AM, "Adjuvant therapy in the treatment of biliary tract cancer : a systematic review and meta-analysis", J Clin Oncol, 30, pp.1934~1940 (2012)
126. Miura JT, "Chemotherapy for surgically resected intrahepatic cholangiocarcinoma", Ann Surg Oncol, 22, pp.3716~3723 (2015)
127. Valle JW, "Cisplatin and gemcitabine for advanced biliary tract cancer : a meta-analysis of two randomised trials", Ann Oncol, 25, pp.391~398 (2014)
128. Borghero Y, "Extrahepatic bile duct adenocarcinoma : patients at high-risk for local recurrence treated with surgery and adjuvant chemoradiation have an equivalent overall survival to patients with standard-risk treated with surgery alone", Ann Surg Oncol, 15, pp.3147~3156 (2008)
129. Bonet Beltrán M, "Is adjuvant radiotherapy needed after curative resection of extrahepatic biliary tract cancers? A systematic review with a meta-analysis of observational studies", Cancer Treat Rev, 38, pp.111~119 (2012)
130. Ben-Josef E, "SWOG S0809 : a phase II intergroup trial of adjuvant capecitabine and gemcitabine followed by radiotherapy and concurrent capecitabine in extrahepatic cholangiocarcinoma and gallbladder carcinoma", J Clin Oncol, 33, pp.2617~2622 (2015)
131. Valle J, "Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer", N Engl J Med, 362, pp.1273~1281 (2010)
132. Eckel F, "Chemotherapy and targeted therapy in advanced biliary tract carcinoma : a pooled analysis of clinical trials", Chemotherapy, 60, pp.13~23 (2014)
133. Shinohara ET, "Radiation therapy is associated with improved survival in the adjuvant and definitive treatment of intrahepatic cholangiocarcinoma", Int J Radiat Oncol Biol Phys, 72, pp.1495~1501 (2008)
134. Mattiucci GC, "Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma", Crit Rev Oncol Hematol, 90, pp.58~67 (2014)
135. Ben-Josef E, "Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies", J Clin Oncol, 23, pp.8739~8747 (2005)
136. Barney BM, "Clinical outcomes and toxicity using stereotactic body radiotherapy(SBRT)for advanced cholangiocarcinoma", Radiat Oncol, 7, pp.67~ (2012)
137. Da Hoon Jung, "Outcomes of stereotactic body radiotherapy for unresectable primary or recurrent cholangiocarcinoma", Radiation oncology journal, 32(3), pp.163~169 (2014), 대한방사선종양학회
138. Ohkawa A, "Proton beam therapy for unresectable intrahepatic cholangiocarcinoma", J Gastroenterol Hepatol, 30, pp.957~963 (2015)
139. Chen Y, "The use of 125I seed strands for intraluminal brachytherapy of malignant obstructive jaundice", Cancer Biother Radiopharm, 27, pp.317~323 (2012)
140. Ghafoori AP, "Radiotherapy in the treatment of patients with unresectable extrahepatic cholangiocarcinoma", Int J Radiat Oncol Biol Phys, 81, pp.654~659 (2011)
141. Válek V, "Brachytherapy and percutaneous stenting in the treatment of cholangiocarcinoma : a prospective randomised study", Eur J Radiol, 62, pp.175~179 (2007)
142. Shinohara ET, "Brachytherapy in the treatment of cholangiocarcinoma", Int J Radiat Oncol Biol Phys, 78, pp.722~728 (2010)
143. Zhang W, "Placement of 125I seed strands and stents for a type IV Klatskin tumor", World J Gastroenterol, 21, pp.373~376 (2015)
144. Mukewar S, "Endoscopically inserted nasobiliary catheters for high dose-rate brachytherapy as part of neoadjuvant therapy for perihilar cholangiocarcinoma", Endoscopy, 47, pp.878~883 (2015)
145. Kasai K, "Efficacy of hepatic arterial infusion chemotherapy using 5-fluorouracil and systemic pegylated interferon α-2b for advanced intrahepatic cholangiocarcinoma", Ann Surg Oncol, 21, pp.3638~3645 (2014)
146. Inaba Y, "Phase I", II study of hepatic arterial infusion chemotherapy with gemcitabine in patients with unresectable intrahepatic cholangiocarcinoma(JIVROSG-0301), 2011, pp.34, 58~62
147. Miura JT, "Transarterial chemoembolization for primary liver malignancies and colorectal liver metastasis", Surg Oncol Clin N Am, 24, pp.149~166 (2015)
148. Vogl TJ, "Transarterial chemoembolization in the treatment of patients with unresectable cholangiocarcinoma : results and prognostic factors governing treatment success", Int J Cancer, 131, pp.733~740 (2012)
149. Scheuermann U, "Comparison of resection and transarterial chemoembolisation in the treatment of advanced intrahepatic cholangiocarcinoma--a single-center experience", Eur J Surg Oncol, 39, pp.593~600 (2013)
150. Aliberti C, "Chemoembolization(TACE)of unresectable intrahepatic cholangiocarcinoma with slow-release doxorubicin-eluting beads : preliminary results", Cardiovasc Intervent Radiol, 31, pp.883~888 (2008)
151. Kuhlmann JB, "Treatment of unresectable cholangiocarcinoma : conventional transarterial chemoembolization compared with drug eluting bead-transarterial chemoembolization and systemic chemotherapy", Eur J Gastroenterol Hepatol, 24, pp.437~443 (2012)
152. Boehm LM, "Comparative effectiveness of hepatic artery based therapies for unresectable intrahepatic cholangiocarcinoma", J Surg Oncol, 111, pp.213~220 (2015)
153. Al-Adra DP, "Treatment of unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization : a systematic review and pooled analysis", Eur J Surg Oncol, 41, pp.120~127 (2015)
154. Rayar M, "Intraarterial yttrium-90 radioembolization combined with systemic chemotherapy is a promising method for downstaging unresectable huge intrahepatic cholangiocarcinoma to surgical treatment", Ann Surg Oncol, 22, pp.3102~3108 (2015)
155. Han K, "Radiofrequency ablation in the treatment of unresectable intrahepatic cholangiocarcinoma : systematic review and meta-analysis", J Vasc Interv Radiol, 26, pp.943~948 (2015)
156. Wu TT, "Percutaneous intraluminal radiofrequency ablation for malignant extrahepatic biliary obstruction : a safe and feasible method", Dig Dis Sci, 60, pp.2158~2163 (2015)
157. Dolak W, "Endoscopic radiofrequency ablation for malignant biliary obstruction : a nationwide retrospective study of 84 consecutive applications", Surg Endosc, 28, pp.854~860 (2014)
158. Sharaiha RZ, "Impact of radiofrequency ablation on malignant biliary strictures : results of a collaborative registry", Dig Dis Sci, 60, pp.2164~2169 (2015)
159. Mukund A, "Endobiliary radiofrequency ablation for reopening of occluded biliary stents : a promising technique", J Vasc Interv Radiol, 24, pp.142~144 (2013)
160. Strand DS, "ERCPdirected radiofrequency ablation and photodynamic therapy are associated with comparable survival in the treatment of unresectable cholangiocarcinoma", Gastrointest Endosc, 80, pp.794~804 (2014)
161. Patel J, "Role of photodynamic therapy and intraductal radiofrequency ablation in cholangiocarcinoma", Best Pract Res Clin Gastroenterol, 29, pp.309~318 (2015)
162. Mönkemüller K, "Endoscopic treatment options for cholangiocarcinomas", Expert Rev Anticancer Ther, 14, pp.407~418 (2014)
163. Witzigmann H, "Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma : palliative photodynamic therapy plus stenting is comparable to r1", r2 resection, 2006, pp.244, 230~239
164. Choi HJ, "Clinical feasibility of direct peroral cholangioscopy-guided photodynamic therapy for inoperable cholangiocarcinoma performed by using an ultra-slim upper endoscope(with videos)", Gastrointest Endosc, 73, pp.808~813 (2011)
165. Patel J, "Cholangioscopy-assisted photodynamic therapy for cholangiocarcinoma", Gastrointest Endosc, 81, pp.1012~1013 (2015)
166. Ortner MA, "Photodynamic therapy of nonresectable cholangiocarcinoma", Gastroenterology, 114, pp.536~542 (1998)
167. Kahaleh M, "Unresectable cholangiocarcinoma : comparison of survival in biliary stenting alone versus stenting with photodynamic therapy", Clin Gastroenterol Hepatol, 6, pp.290~297 (2008)
168. Lee TY, "Photodynamic therapy prolongs metal stent patency in patients with unresectable hilar cholangiocarcinoma", World J Gastroenterol, 18, pp.5589~5594 (2012)

관련 논문AI추천